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Abstract
Introduction: Although the incidence of Plasmodium falciparum malaria in some parts of sub-Saharan Africa is reported to
decline and other conditions, causing similar symptoms as clinical malaria are gaining in relevance, presumptive anti-
malarial treatment is still common. This study traced for age-dependent signs and symptoms predictive for P. falciparum
parasitaemia.
Methods: In total, 5447 visits of 3641 patients between 2–60 months of age who attended an outpatient department (OPD)
of a rural hospital in the Ashanti Region, Ghana, were analysed. All Children were examined by a paediatrician and a full
blood count and thick smear were done. A Classification and Regression Tree (CART) model was used to generate a clinical
decision tree to predict malarial parasitaemia a7nd predictive values of all symptoms were calculated.
Results: Malarial parasitaemia was detected in children between 2–12 months and between 12–60 months of age with a
prevalence of 13.8% and 30.6%, respectively. The CART-model revealed age-dependent differences in the ability of the
variables to predict parasitaemia. While palmar pallor was the most important symptom in children between 2–12 months, a
report of fever and an elevated body temperature of $37.5uC gained in relevance in children between 12–60 months. The
variable palmar pallor was significantly (p,0.001) associated with lower haemoglobin levels in children of all ages.
Compared to the Integrated Management of Childhood Illness (IMCI) algorithm the CART-model had much lower
sensitivities, but higher specificities and positive predictive values for a malarial parasitaemia.
Conclusions: Use of age-derived algorithms increases the specificity of the prediction for P. falciparum parasitaemia. The
predictive value of palmar pallor should be underlined in health worker training. Due to a lack of sensitivity neither the best
algorithm nor palmar pallor as a single sign are eligible for decision-making and cannot replace presumptive treatment or
laboratory diagnosis.
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Introduction
According to the latest figures of the World Health Organiza-
tion (WHO) there were 225 million cases of malaria estimated for
the year 2009, responsible for 781000 deaths [1]. Although
decreasing numbers of malaria cases and mortality are reported in
all WHO Regions, Africa remains the continent with the largest
proportion of deaths caused by the disease [1–4]. In 2009, ninety-
one percent of malaria fatalities worldwide occurred in Africa,
85% of these deaths were in children under 5 years of age [5]. The
WHO implemented the Integrated Management of Childhood
Illness (IMCI) Programme in 1997 as a systematic approach to
children’s health in response to increasing numbers of deaths in
children under five years of age [6].
The IMCI-system should enable health workers in rural areas to
identify severely ill children using simple evidence based clinical
algorithms [7]. Since the beginning of the programme improve-
ments of health care quality with an effect on child health have
been reported [8–10]. During the 90’s and the early first decade of
2000 several attempts have been undertaken to establish clinical
algorithms that enable health workers in poor settings to diagnose
malaria based on clinical features in children [11–16]. The IMCI-
algorithm bases on a few symptoms and parameters with high
sensitivities but low specificities for the classification of malaria.
Consequently, over-treatment and drug wastage were frequent
points of criticism [2,17,18].
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36678Within the last 14 years after implementation of IMCI in 44 of
46 African countries, some of the general conditions in these
countries have changed [19]. Health worker performance
improved, health care seeking behaviour of parents was enhanced
and distribution of anti-malarials, antipyretics and insecticide
treated bed-nets (ITNs) was extended [1,2,20]. On the other hand,
the proportion of other diseases presented by children in health
facilities with overlapping symptoms to malaria has been
increasing [1,2,21].
The aim of the present study is to generate an age-derived
clinical algorithm with simple signs and symptoms for the
diagnosis of Plasmodium falciparum parasitaemia.
An algorithm such as this could help to detect focus groups of
children for presumptive treatment if resources are scarce. For
better adoption to the clinical decision-making, we used a
Classification and Regression Tree model (CART).
Methods
Study setting
This study was conducted in Agogo, Ghana, which is located in
the Agogo District, 80 kilometres east of the regional capital
Kumasi. The population in the Agogo District and the
neighboured Ashanti Akim North District is estimated with
140.000. The climate is tropical, and the entire Ashanti region is
holoendemic for malaria. Transmission of parasites is stable with
an estimated entomological inoculation rate (EIR) of .400 per
year [22]. The predominant malaria parasite is P. falciparum [23].
The Agogo Presbyterian Hospital (APH) is a 250-bed facility,
divided in five departments and employs 19 doctors.
Data collection
Children aged up to 5 years who visited the Outpatient
Department for any illness in the period between May 2007 and
July 2009 were included in the study. Body temperature, weight
and height were measured and documented in a Case Report
Form (CRF) with predefined clinical criteria by trained study
nurses. Afterwards a pediatrician interviewed the caretaker of the
child and carried out a physical examination. Three nurses and
two doctors were working in the OPD at the same time. All clinical
symptoms were assessed before health personnel had access to
laboratory data.
A report of fever was defined as any history of intermittent or
continuous fever or ‘feeling hot’ within the last five days. An elevated
body temperature was defined as a temperature of $37.5uC or above.
An EDTA-blood sample was collected for full blood count and
Giemsa-stained thick and thin blood films. The outcome of the
CART models was P. falciparum parasitaemia of any density.
Data Management and processing for database
A patient was defined as an individual visiting the OPD. Every
individual visiting the OPD without a previous visit within 14 days
was included as a ‘‘new patient’’.
CRF and laboratory results were double entered within
48 hours into a database (4
th Dimension, 4D SAS, France).
Inconsistencies were checked by a data manager. Statistical
analyses were carried out using STATA IC/10.0 statistical and
data analysis software (Stata Cooperation, California).
Of 8283 visits of 4981 individuals during the study period, only
those were included in the calculations, which had a malaria smear
result available (Table 1, Figure 1). Cases that had missing values
for one of the variables in Table 2 were also not included in further
analyses. After exclusion of cases with incomplete information,
5447 visits of 3641 individuals were left.
Data analysis
Each variable from Table 2 was put in a bivariate regression
analysis to compute Odds Ratios between symptoms and
parasitaemia. The resulting Odds Ratios were used to decide
whether the variables are handled as potentially predictive. Those
variables providing both, an Odds Ratio #0.83 or $1.20 and an
occurrence in at least 1% of cases with present parasitaemia were
put in a forward and a backward stepwise logistic regression. For
variables with an Odds Ratio #0.83 bunched inverse variables
were generated (e.g. no respiratory symptoms).
For stepwise estimation a p-value of ,0.05 was set as a statistical
cut-off. Variables that were significantly associated with parasit-
aemia were then entered in the CART – analysis for the
generation of an algorithm, which could be suitable for clinical
routine.
Beginning with a parent node containing all cases of a specific
age group, CART is continuously trying to maximize the purity,
i.e. to segregate children who are affected by parasitaemia from
those children who are not affected. Therefore, the model
generates a decision tree by splitting the cases of the parent node
at an optimal split point where the arising child nodes provide
greater purity (better segregation of affected and non-affected
children). For detection of the optimal split point the entered
binary prediction variables were used.
Every child node in turn can become a parent node, as CART
continues the splitting process until statistical analysis indicates
that another child node would not be of greater purity [24,25].
The resulting tree is structured as a sequence of yes/no questions.
For calculation of cut-points a p-value of ,0.05 and a minimum
size of the subgroup of 10 cases were set. CART-analyses were
separately carried out for two different age groups (2–12 months
and 12–60 months).
Sensitivity, specificity, negative (NPV) and positive (PPV)
predictive values were calculated for each CART-model and
compared to the IMCI-algorithm. Haemoglobin (Hb)-values of
children with palmar pallor were compared to those without. For
testing the null hypothesis on this variable an unpaired two-sample
t-test was performed, assuming a Student’s t distribution. To
discover potiential over-representation of palmar pallor due to the
effect of multipe visits of single individuals a McNemar test was
used. Additionally, an alternative CART model was created for
both age groups containing only the first visit of every individual.
Methodology of laboratory examinations
For analysis of the capillary blood samples, a SysmexH KX-21N
Haematological Analyzer (Sysmex Corporation, Kobe, Japan) was
used. The machine was tested and calibrated on a daily basis. A
three level control (Eightcheck-3WP controls (Low, Normal and
High)) were run each morning to ensure the function of the
machine.
Thick and thin blood smears were prepared for each child
enrolled in the study, stained with 10% Giemsa working solution
and examined by using immersion oil microscopy with 1006
magnification for detection, species identification and quantifica-
tion of malaria parasites. The number of P. falciparum parasites per
200 white blood cells (thick smear) or in case of very high
parasitaemia per 1000 erythrocytes (thin film) was assessed and
densities were recorded as the number of parasites/ml of blood.
As predictive signs and symptoms for P. falciparum parasitaemia
were traced, a child was considered to be parasitaemic at any
density of parasites, i.e. there was no parasite density threshold set.
If there was no blood count available, an average of 8000
leucocytes per ml of blood was assumed [26].
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The study was conducted in accordance with the ethical
principles of the Declaration of Helsinki, and consistent with Good
Clinical Practice (GCP). Ethical approval for the study was
obtained from the Ethics committees of the School of Medical
Science, Kwame Nkrumah University of Science and Technology
(KNUST), Kumasi.
Mothers or guardians of children were informed about the aim
of the study in presence of a witness and their understanding was
assessed by a set of standard questions. Informed consent was
sought from mothers who granted it by signature or thumbprint.
Results
Describing the population
We included 5447 patients under 5 years of age (3641
individuals) in the analyses, 52.9% were male. About 23.9% of
all children were between 2–12 months old and 76.1% of children
between 12–60 months. The prevalence of P. falciparum parasit-
aemia increased with age from 13.8% to 30.6% (Table 1).
Predictive value of clinical symptoms
Table 2 shows the clinical symptoms for prediction of
parasitaemia in a bivariate regression analysis. All variables with
both characteristics, an Odds Ratio #0.83 or $1.20 and an
occurrence in at least 1% of cases with present parasitaemia, were
entered in the forward and backward stepwise estimation (not
displayed). Both parameter reduction methods revealed the
following variables to be able to predict a parasitaemia: Palmar
pallor with an OR of 3.06 (95%-CI: 2.49–3.78; p,0.001), elevated
body temperature with an OR of 2.82 (95%-CI: 2.47–3.23; p,0.001),
report of fever with an OR of 4.62 (95%-CI: 3.39–6.30; p,0.001),
other skin problem with an OR of 2.25 (95%-CI: 1.47–3.47;
p,0.001), vomiting with an OR of 1.33 (95%-CI: 1.16–1.52;
p,0.001), no respiratory symptoms with an OR of 2.45 (95%-CI:
2.14–2.81; p,0.001), no skin symptoms with an OR of 1.97 (95%-
CI: 1.51–2.56; p,0.001) and no malnourishment with an OR of 1.71
(95%-CI: 1.08–2.76; p,0.025). These variables were then
included in the CART-analyses.
Figure 1. Enrollment and exclusion of patients for analysis.
a A patient is defined as an individual visiting the OPD.
b Case report forms must
have information for each variable in Table 2 available.
doi:10.1371/journal.pone.0036678.g001
Table 1. Characteristics of 5447
b patient visits in the study.
Total No Parasites detected
a Parasites detected
a
n=5447
b n=3998
b n=1449
b
Sex Male (%) 2882 2112 (73.3) 770 (26.7)
Female (%) 2565 1886 (73.5) 679 (26.5)
Age, months 2–12 (%) 1304 1124 (86.2) 180 (13.8)
12–60 (%) 4143 2874 (69.4) 1269 (30.6)
Residence Agogo (%) 2526 1768 (70.0) 758 (30.0)
Outside Agogo (%) 2921 2230 (76.3) 691 (23.7)
aPresence of P. falciparum parasites was analyzed by thick blood smear or thin blood film.
b5447 visits of 3641 individuals were included in the study.
doi:10.1371/journal.pone.0036678.t001
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The CART-analysis was performed separately for the two age
groups. In children between 2–12 months of age, the first decision
was made by whether the patient was diagnosed with palmar pallor
or not (Figure 2). In 19 children out of 29 who presented with
palmar pallor but without respiratory symptoms (no respiratory
symptoms=1) a P. falciparum parasitaemia was detected
(OR=4.75). To the contrary, patients without palmar pallor,
without an elevated body temperature ($37.5uC) on admission and
without any report of fever in the last five days had an OR of 0.14 for
parasitaemia. For those children, who had a positive report of fever,
the likelihood of having parasitaemia was slightly higher with an
OR of 0.73.
Compared to the CART-model for children between 12–60
months several differences were obvious (Figure 3). While palmar
pallor was strongly predictive for parasitaemia in children between
2–12 months of age, it generated only small differences of the OR
in older children where elevated body temperature was the first decisive
Table 2. Signs and symptoms and their association with P. falciparum parasitaemia in children.
Signs and Symptoms Patient visits
No parasites
detected Parasites detected
Odds
Ratio 95% – CI
e p
N=5447 N=3998 N=1449
n (%) n (%) n (%)
Signs or symptoms assessed by nurse or doctor
Running Nose 3074 (56.4) 2466 (61.7) 608 (42.0) 0.44 0.39–0.50 ,0.001
Elevated body temperature 2025 (37.2) 1143 (28.6) 882 (60.9) 1.97 1.86–2.09 ,0.001
Blocked nose 762 (14.0) 631 (15.8) 131 (9.0) 0.53 0.43–0.64 ,0.001
Skin rash 621 (11.4) 530 (13.3) 91 (6.3) 0.43 0.34–4.52 ,0.001
Palmar pallor 477 (8.8) 218 (5.5) 259 (17.9) 2.80 2.38–3.30 ,0.001
Skin abnormalities 344 (6.3) 268 (6.7) 76 (5.2) 0.77 0.59–1.00 0.051
Other skin problem 179 (3.3) 122 (3.1) 57 (3.9) 1.30 0.94–1.79 0.107
Malnourished condition 136 (2.5) 110 (2.8) 26 (1.8) 0.64 0.41–0.99 0.047
Prostration 115 (2.1) 61 (1.5) 54 (3.7) 2.49 1,72–3,62 ,0.001
Fast breathing 88 (1.6) 72 (1.8) 16 (1.1) 0.60 0.35–1.05 0.074
Jaundice 82 (1.5) 35 (0.9) 47 (3.2) 3.79 2.44–5.90 ,0.001
Breathing difficulties 60 (1.1) 50 (1.3) 10 (0.7) 0.54 0.27–1.08 0.084
Chest indrawing 59 (1.1) 46 (1.2) 13 (0.9) 0.77 0.41–1.44 0.426
Respiratory distress 58 (1.1) 40 (1.0) 18 (1.2) 1.24 0.71–2.17 0.443
Skin depigmentation 51 (0.9) 45 (1.1) 6 (0.4) 0.36 0.15–0.85 0.021
Deep Breathing 33 (0.6) 24 (0.6) 9 (0.6) 1.03 0.48–2.23 0.930
Pinch abdomen present 21 (0.4) 20 (0.5) 1 (0.1) 0.13 0.01–1.02 0.053
Cyanosis 1 (0.01) 0 (0) 1 (0.1) 0.91 0.09–8.79 0.938
Signs or symptoms taken from history by child, parent or legal guardian
Report of fever 3859 (70.8) 2647 (66.2) 1212 (83.6) 2.61 2.23–3.04 ,0.001
Nutrition changed to poor feeding 3659 (67.2) 2617 (65.5) 1042 (71.9) 1.32 1.16–1.50 ,0.001
Cough 3081 (56.6) 2500 (62.5) 581 (40.1) 0.40 0.35–0.45 ,0.001
Vomiting 1870 (34.3) 1275 (31.9) 595 (41.1) 1.48 1.31–1.68 ,0.001
Diarrhoea 1636 (30) 1264 (31.6) 372 (25.7) 0.74 0.65–0.85 ,0.001
Drinking thirsty 425 (7.8) 284 (7.1) 141 (9.7) 1.40 1.14–1.74 0.001
Earpain 172 (3.2) 135 (3.4) 37 (2.6) 0.74 0.51–1.08 0.126
Convulsions 20 (0.4) 12 (0.3) 8 (0.6) 1.84 0.75–4.52 0.180
Generated signs or symptoms
No malnourishment
a 5311 (97.5) 3888 (97.2) 1423 (98.2) 1.55 1.01–2.38 0.047
No skin symptoms
b 4687 (86.1) 3374 (84.4) 1313 (90.6) 1.79 1.47–2.17 ,0.001
No gastrointestinal symptoms
c 2682 (49.2) 2019 (50.5) 663 (45.8) 0.82 0.73–0.93 0.002
No respiratory symptoms
d 1639 (30.1) 1002 (25.1) 637 (44.0) 2.34 2.06–2.66 ,0.001
aTo be positive for this (inverse) variable patients must not present malnourished condition.
bTo be positive for this (inverse) variable patients must not present skin abnormalities, skin rash, skin depigmentation and other skin problem.
cTo be positive for this (inverse) variable patients must not present vomiting and diarrhoea.
dTo be positive for this (inverse) variable patients must not present respiratory distress, breathing difficulties, fast breathing, deep breathing, chest indrawing, running nose,
blocked nose and cough.
eCI: 95% Confidence interval.
doi:10.1371/journal.pone.0036678.t002
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children without elevated body temperature and without report of fever
(OR of 0.22 for malarial parasitaemia). On the other hand an
elevated body temperature and absence of respiratory symptoms
resulted in the highest risk for parasitaemia (OR 2.18).
As expected, Hb levels were significantly lower for those
children who were diagnosed with palmar pallor (Figure 4). Children
aged between 2 and 12 months had a mean Hb level of 7.7 g/dl if
palmar pallor was present and 10.2 g/dl if not (p,0.001). Children
aged between 12 and 60 months with palmar pallor and those
without had a mean Hb of 8.1 g/dl and 10.4 g/dl, respectively
(p,0.001). The McNemar-test showed no heterogeneity
(p=0.343) for the symptom palmar pallor between patients who
had only one visit to the OPD and those patients who came for
more than one time (Table S1). An alternative CART-model that
included only the first visit of every individual also showed no
deviance from the original models (Figure S1 and S2).
In Table 3 data on the sensitivity and the specificity for the
prediction of P. falciparum parasitaemia are shown for the five
variables that remained in the CART analyses. In both age groups
the proportion of children with a report of fever is larger than the
proportion of children who are actually presenting with an elevated
body temperature on admission. In both age-derived models, palmar
pallor has the highest specificity of all variables for predicting a
malarial parasitaemia.
Classification and comparison of the CART-model and
the IMCI-algorithm
For calculation of sensitivity, specificity, positive- and negative
predictive value, we created a logistic regression model containing
all variables used in the corresponding model (Table 4). Regarding
children between 2–12 months, the algorithm provided in the
IMCI system gains a much higher sensitivity of 97.2% than the
CART-model (6.7%), but remains unspecific in the prediction of
parasitaemia with a specificity of 22.2% versus 99.6% in the
CART-model. For the older children these relations were
decreasing, as the IMCI-algorithm provided a sensitivity of
55.6% and a specificity of 73.4% vs. 37.7% and 91.4% for the
CART-model, respectively.
Overall, the CART-model results in much higher specificities
and higher positive predictive values for prediction of malarial
parasitaemia in comparison to the IMCI-model, which provides
higher sensitivities and negative predictive values.
Discussion
We aimed to generate a simple clinical algorithm to predict
malarial parasitaemia in sick children attending a health facility by
means of a Classification and Regression Tree (CART) model.
The hierarchical CART-based decision algorithm increased the
prediction specificity for malarial parasitaemia in comparison to a
simple combination of single parameters. However, despite of a
good specificity of the best model, a significant proportion of
children with malaria would have been overseen with this clinical
algorithm due to a lack of appropriate sensitivity. The use of
clinical algorithms cannot replace laboratory diagnosis or RDT’s
for treatment decisions. In case of unavailability of these tests,
presumptive treatment of children with suspected malaria is
necessary.
A clinical algorithm, given the predictive values are appropriate,
would facilitate the decision for presumptive treatment of certain
focus groups. Apart from earlier studies, we observed all children
between 2 and 60 months of age attending an OPD during the
study period. To gain more knowledge about the relevance of the
symptom fever for the prediction of parasitaemia, we decided not
to use ‘fever’ or a ‘history of fever’ as an inclusion criterion.
Instead, all children visiting the OPD were included. Accordingly,
the primary outcome was defined as ‘Plasmodium falciparum
parasitaemia’ instead of ‘clinical malaria’, which is commonly
defined as presence of parasites and fever or a history of fever
[11,13,15].
Figure 2. CART – model for children between 2 and 12 months of age (N=1304).
1 Number of patients with the respective combination of
variables given by the branches of the decision tree.
2 Number of patients positive for P. falciparum parasitaemia.
3 Odds Ratio for P. falciparum
parasitaemia with the combination of variables in comparison to all other combinations.
doi:10.1371/journal.pone.0036678.g002
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low prevalence of malaria parasitaemia, which may have been due
to the fact, that we enrolled all children who presented to the OPD
for any illness during the study period, disregarding any
prerequisites [27–29]. Children (12–60 months) were more
affected by parasitaemia than infants (2–12 months), which is in
line with earlier findings.
Figure 3. CART – model for children between 12 and 60 months of age (N=4143).
1 Number of patients with the respective combination of
variables given by the branches of the decision tree.
2 Number of patients positive for P. falciparum parasitaemia.
3 Odds Ratio for P. falciparum
parasitaemia with the combination of variables in comparison to all other combinations.
doi:10.1371/journal.pone.0036678.g003
Figure 4. Distribution of haemoglobin-values in patients of different ages with and without palmar pallor. p-value was calculated
assuming a Student’s t distribution.
doi:10.1371/journal.pone.0036678.g004
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e36678In contrast to other studies a CART model was used, a method
discussed controversially. Nevertheless, CART is – compared to
multiple logistic regression – expected to be more suitable for data
where interactions occur [30].
Beyond five symptoms that were used by the CART-model, the
symptoms palmar pallor, elevated body temperature on admission and
report of fever revealed age-dependent differences in the ability to
predict malarial parasitaemia.
Pallor caused by anaemia is a common sign in SSA, in our study
it was noticed in 8.8% of all cases [31–33]. The impact of palmar
pallor through all CART algorithms revealed the importance of the
symptom as predictor of P. falciparum infection. In the model for
the youngest children (Figure 2) palmar pallor was even selected as
the first decisive variable. Investigation of full blood counts
showed, that palmar pallor could predict parasitaemia even in
children from this population with a high prevalence of anaemia.
Indeed, children with palmar pallor had significantly lower Hb-levels
than those who were not diagnosed as being pale on their palms
(Figure 4). Previous studies showed diverse results on the ability of
health workers to recognize pallor [32,34,35]. Health workers in
high malaria transmission areas had less difficulties [36].
We considered two different fever definitions. Although it
provides higher sensitivity, a report of fever was of lower priority in all
CART-models, than an elevated body temperature. In children below
the age of 12 months, fever did not count for the branch of our
CART model with the highest predictivity. Even though studies
demonstrated that mothers are able to identify an elevated body
temperature in their children with sensitivites up to 76%, a report of
fever given by the caretaker remains relatively unspecific [37]. Our
data showed specificities below 24% for the variable report of fever
predicting P. falciparum parasitaemia in both age groups. Most of
the febrile episodes reported could not be confirmed with
thermometers on admission, probably due to the use of
antipyretics. This finding was also observed in other studies
[13,38].
Application of the CART algorithm showed that the predictive
value of fever was increasing with the age of the children. In
contrast, palmar pallor had a much higher impact in infants.
However, these symptoms were applied in the context of an
algorithm and as in previous studies we can confirm that higher
developed algorithms are able to provide much higher specificities,
when compared to the IMCI-algorithm, but lack in sensitivity. For
children between 2 and 12 months IMCI gives a sensitivity of
97.2% and a specificity of 22.2%, CART provides 6.7% and
99.6%, respectively. Vital for the decision of the health worker and
for the health of the patient are the predictive values, which are
dependent on the prevalence of the outcome. With decreasing
prevalences of malaria the negative predictive value will increase
and the positive predictive value will decrease given the same
sensitivity and specificity of the algorithm. Comparison of our
approach to IMCI may be aggravated as our outcome was P.
falciparum parasitaemia and IMCI mainly targets clinical malaria.
The algorithm itself is not eligible to make treatment decisions
without laboratory support or even to withheld anti-malarials to
children with suspected malaria.
During the last two years there is an ongoing debate, whether to
move away from presumptive treatment of febrile children for
malaria to laboratory-confirmed treatment. Proponents mainly
refer to the substantial decline of malaria transmission and the
availability of reliable rapid diagnostic tests (RDT’s) [2,39–41]
while others raised the concern that health system capacity is not
yet sufficient to implement such a policy change [42].
Health workers in primary health care indeed play a key role for
correct assessment and treatment of children with malaria. They
are frequently forced to decide about treatment under great
pressure, because often children are presented to them only once,
due to access barriers to hospitals such as long travel distances,
costs or lack of health insurance coverage [43]. As our results
show, it would be appropriate to sensitize health workers for the
sign of palmar pallor as a symptom possibly predicting malarial
parasitaemia, especially in infants. However, the symptom is not
Table 3. Sensitivity and specificity of symptoms for
prediction of P. falciparum parasitaemia in different age
groups.
Patients 2–12 months 12–60 months
ROF
a N (%) 1029 (78.9) 3539 (85.4)
Sens./Spec. 96.0/23.8 96.8/19.6
EBT
b N (%) 465 (35) 1569 (37.9)
Sens./Spec. 56.7/68.5 61.5/72.5
Palmar Pallor N (%) 90 (6.9) 387 (9.3)
Sens./Spec. 21.7/95.5 17.3/94.2
Vomiting N (%) 549 (42.1) 1321 (31.9)
Sens./Spec. 40.0/57.6 41.2/72.2
NRS
c N (%) 340 (26.1) 1299 (31.6)
Sens./Spec. 38.9/76 44.7/74.5
Note: Percentage refers to the total number of patients within each age group.
aROF=report of fever;
bEBT=elevated body temperature;
cNRS=no respiratory symptoms.
doi:10.1371/journal.pone.0036678.t003
Table 4. Classification and comparison of CART model and IMCI algorithm.
Age (months) Model Sensitivity (%) Specificity (%) PPV
c (%) NPV
d (%)
2–12 IMCI-algorithm
a 97.2 22.2 16.7 98.0
(n=1304) CART-model
b 6.7 99.6 75.0 87.0
12–60 IMCI-algorithm
a 55.6 73.4 48.0 78.9
(n=4143) CART-model
b 37.7 91.4 65.8 76.9
aIMCI-algorithm for identification of children with malaria in high-risk areas: Fever by history of fever or feeling hot/elevated body temperature of $37.5uC on admission
and/or some palmar pallor.
bCART-model: For calculation only those variables were used, which were included in the CART-analysis for the certain age group.
cPPV=Positive predictive value.
dNPV=Negative predictive value.
doi:10.1371/journal.pone.0036678.t004
Predictive Symptoms for P. falciparum Parasitaemia
PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e36678eligible to be applied for making a treatment decision. Instead of
this, continuous reviews of patients could lead to more conserva-
tive treatment strategies. It is further necessary to keep on track
with distribution of equipment for malaria diagnostics.
Conclusions
The value of the symptoms fever and palmar pallor to predict P.
falciparum parasitaemia is age-dependent. Palmar pallor is easy to
recognize and might be helpful for health workers as an indicator
not only for anaemia but also for malarial parasitaemia whereas
this clinical sign cannot replace thorough laboratory diagnostics.
Supporting Information
Figure S1 CART – model for the first visit* of children between
2 and 12 months of age (N=1031).
* CART-model was calculated
only for the first visit of each individual. Subsequent visits of
individuals were excluded from the analysis.
1 Number of patients
with the respective combination of variables given by the branches
of the decision tree.
2 Number of patients positive for P. falciparum
parasitaemia.
3 Odds Ratio for P. falciparum parasitaemia with the
combination of variables in comparison to all other combinations.
(TIF)
Figure S2 CART – model for the first visit* of children between
12 and 60 months of age (N=2610).
* CART-model was
calculated only for the first visit of each individual. Subsequent
visits of individuals were excluded from the analysis.
1 Number of
patients with the respective combination of variables given by the
branches of the decision tree.
2 Number of patients positive for P.
falciparum parasitaemia.
3 Odds Ratio for P. falciparum parasitaemia
with the combination of variables in comparison to all other
combinations.
(TIF)
Table S1 Re-occurrence of palmar pallor in 1125 patients who
had multiple visits (n=2931) to the Outpatient department.
McNemar-test: chi
2: 0.90; degrees of freedom:1; Prob.chi
2:
0.343.
(DOC)
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